EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/78716
March 2012 those getting lower levels of calcium daily. Similarly for iron, she reported that those receiving more than 18 mg/day were 3.8-fold more likely to self-report glaucoma compared to those getting less daily iron. For those consuming high levels of both nutrients, the risk was 7.2-fold higher. "Oxidative stress may be an important component of the glau- coma disease process," she hypothe- sized. These elements play a role in generating highly reactive species that could be involved in the patho- physiology of the disease, she said. EW Editors' note: Dr. Ahmed has financial interests with AMO, Alcon (Fort Worth, Texas), Allergan (Irvine, Calif.), and New World Medical. Dr. Baerveldt is the developer of the Baerveldt implant. Dr. Chrystakis has no financial inter- ests related to his comments. Dr. Coleman has financial interests with Pfizer (New York). Dr. Feldman has financial interests with Alcon and Merck (Whitehouse Station, N.J.). Dr. Greenfield has no financial interests related to his comments. Dr. Heuer has financial interests with Alcon. Dr. Mansberger has financial interests with Santen (Osaka, Japan), Allergan, Glaukos (Laguna Hills, Calif.), Genen- tech (South San Francisco), and Merck. Dr. Reynolds has financial interests with iScience (Menlo Park, Calif.), Ivantis (Irvine, Calif.), Merck, and Alcon. Dr. Rosenberg has no financial interests related to her comments. Dr. Bhorade has no financial interests re- lated to her comments. Dr. Burgoyne has financial interests with Allergan and Heidelberg Engineering (Heidelberg, Germany). Dr. de Moraes has no finan- cial interests related to his comments. Dr. Goldberg has no financial interests related to his comments. Dr. Huang has financial interests with Optovue Inc. (Fremont, Calif.) and Carl Zeiss Meditec (Dublin, Calif.). Dr. Medeiros has financial interests with Allergan, Alcon, Carl Zeiss Meditec, and Merck. Dr. Nickells has no financial interests related to his comments. Dr. Weinreb has financial interests with Alcon, Allergan, Bausch + Lomb (Rochester, N.Y.), Carl Zeiss Meditec, Glaxo (Middlesex, U.K.), Genentech, Implandata (Germany), Altheos (San Francisco), Merck, Novartis (Basel, Switzerland), Optovue Inc., Sensimed (Lausanne, Switzerland), SOLX (Boston), Topcon Medical Systems (Tokyo), Lumenis (Santa Clara, Calif.), Nidek (Fremont, Calif.), Novartis, and Haag-Streit (Mason, Ohio). Dr. Caprioli has financial interests with Alcon, Allergan, and Pfizer. Dr. Mansuri has financial interests with Sensimed. Dr. Radcliffe has financial interests with Alcon, Allergan, Carl Zeiss Meditec, and Ophthalmic Imag- ing Systems (Sacramento, Calif.). Dr. Ramulu has no financial interests related to his comments. Dr. Rhee has financial interests with Alcon, Allergan, Merck, Novagali Pharma (Envy, France), and Santen. Dr. Sit has financial interests with Alcon, Allergan, Bausch + Lomb, Ivantis, Santen, and Transcend Medical (Menlo Park, Calif.). Ms. Wang has no financial interests related to her comments.